Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma

Gynecologic Oncology

Volumn 112, Issue 2, 2009, Pages 314-318

  Yang, Guo Fen ^a,b   Xie, Dan ^a   Liu, Ji Hong ^a   Luo, Jun Hang ^b   Li, Li Juan ^b   Hua, Wen Feng ^a   Wu, Hong Mei ^a   Kung, Hsiang Fu ^a   Zeng, Yi Xin ^a   Guan, Xin Yuan ^a,c  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Amplification; EIF 5A2; Immunohistochemistry; Ovarian carcinoma; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CONTROLLED STUDY; CYSTADENOMA; EIF 5A2 GENE; FEMALE; GENE; GENE AMPLIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CARCINOMA; OVARY TUMOR; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; CYSTADENOMA; FEMALE; GENE AMPLIFICATION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KI-67 ANTIGEN; MIDDLE AGED; OVARIAN NEOPLASMS; PARAFFIN EMBEDDING; PEPTIDE INITIATION FACTORS; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 58149485132     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.10.024     Document Type: Article

References (29)

1. Wingo P.A., Ries L.A., Rosenberg H.M., Miller D.S., and Edwards B.K. Cancer incidence and mortality, 1973-1995, a report card for the U.S. Cancer 82 6 (1998) 1197-1207
2. Lynch H.T., Casey M.J., Lynch J., White T.E., and Godwin A.K. Genetics and ovarian carcinoma. Semin. Oncol. 25 3 (1998) 265-280
3. Runnebaum I.B., and Stickeler E. Epidemiological and molecular aspects of ovarian cancer risk. J Cancer Res Clin. Oncol. 127 2 (2001 Feb) 73-79
4. DiSaia P.J., and Bloss J.D. Treatment of ovarian cancer: new strategies. Gynecol. Oncol. 90 2 Pt 2 (2003) S24-32
5. Iwabuchi H., Sakamoto M., Sakunaga H., Ma Y.Y., Carcangiu M.L., Pinkel D., et al. Genetic analysis of benign, low-grade, and high-grade ovarian tumors. Cancer Res. 55 24 (1995 Dec 15) 6172-6180
6. Arnold N., Hagele L., Walz L., Schempp W., Pfisterer J., Bauknecht T., et al. Overrepresentation of 3q and 8q material and loss of 18q material are recurrent findings in advanced human ovarian cancer. Genes Chromosomes Cancer 16 1 (1996) 46-54
7. Sonoda G., Palazzo J., du Manoir S., Godwin A.K., Feder M., Yakushiji M., et al. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas. Genes Chromosomes Cancer 20 4 (1997) 320-328
8. Sham J.S., Tang T.C., Fang Y., Sun L., Qin L.X., Wu Q.L., et al. Recurrent chromosome alterations in primary ovarian carcinoma of Chinese women. Cancer Genet. Cytogenet. 133 1 (2002) 39-44
9. Pack S.D., Karkera J.D., Zhuang Z., Pak E.D., Balan K.V., Hwu P., et al. Molecular cytogenetic fingerprinting of esophageal squamous cell carcinoma by comparative genomic hybridization reveals a consistent pattern of chromosomal alterations. Genes Chromosomes Cancer 25 2 (1999) 160-168
10. Kettunen E., el-Rifai W., Björkqvist A.M., Wolff H., Karjalainen A., Anttila S., et al. A broad amplification pattern at 3q in squamous cell lung cancer-a fluorescence in situ hybridization study. Cancer Genet. Cytogenet. 117 1 (2000) 66-70
11. Guan X.Y., Fu S.B., Xia J.C., Fang Y., Sham J.S., Du B.D., et al. Recurrent chromosome changes in 62 primary gastric carcinomas detected by comparative genomic hybridization. Cancer Genet. Cytogenet. 123 1 (2000) 27-34
12. He Q.J., Zeng W.F., Sham J.S., Xie D., Yang X.W., Lin H.L., et al. Recurrent genetic alterations in 26 colorectal carcinomas and 21 adenomas from Chinese patients. Cancer Genet. Cytogenet. 144 2 (2003) 112-118
13. Fang Y., Guan X., Guo Y., Sham J., Deng M., Liang Q., et al. Analysis of genetic alterations in primary nasopharyngeal carcinoma by comparative genomic hybridization. Genes Chromosomes Cancer 30 3 (2001) 254-260
14. Rao P.H., Arias-Pulido H., Lu X.Y., Harris C.P., Vargas H., Zhang F.F., et al. Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma. BMC Cancer 4 (2004) 5-11
15. Guan X.Y., Sham J.S., Tang T.C., Fang Y., Huo K.K., and Yang J.M. Isolation of a novel candidate oncogene within a frequently amplified region at 3q26 in ovarian cancer. Cancer Res. 61 9 (2001) 3806-3809
16. Guan X.Y., Fung J.M., Ma N.F., Lau S.H., Tai L.S., Xie D., et al. Oncogenic role of eIF-5A2 in the development of ovarian cancer. Cancer Res. 64 12 (2004) 4197-4200
17. Marchet A., Mocellin S., Belluco C., Ambrosi A., DeMarchi F., Mammano E., et al. Gene expression profile of primary gastric cancer: towards the prediction of lymph node status. Ann. Surg. Oncol. 14 3 (2007) 1058-1064
18. Ojima E., Inoue Y., Miki C., Mori M., and Kusunoki M. Effectiveness of gene expression profiling for response prediction of rectal cancer to preoperative radiotherapy. J. Gastroenterol. 42 9 (2007) 730-736
19. Xie D., Ma N.F., Pan Z.Z., Wu H.X., Liu Y.D., Wu G.Q., et al. Overexpression of EIF-5A2 is associated with metastasis of human colorectal carcinoma. Hum. Pathol. 39 1 (2008) 80-86
20. Xie D., Zeng Y.X., Wang H.J., Wen J.M., Tao Y., Sham J.S., et al. Expression of cytoplasmic and nuclear Survivin in primary and secondary human glioblastoma. Br. J. Cancer 94 1 (2006) 108-114
21. Luo J.H., Xie D., Liu M.Z., Chen W., Liu Y.D., Wu G.Q., et al. Protein expression and amplification of AIB1 in human urothelial carcinoma of the bladder and overexpression of AIB1 is a new independent prognostic marker of patient survival. Int. J. Cancer 122 11 (2008) 2554-2561
22. Jenkins Z.A., Hååg P.G., and Johansson H.E. Human eIF5A2 on chromosome 3q25-q27 is a phylogenetically conserved vertebrate variant of eukaryotic translation initiation factor 5A with tissue-specific expression. Genomics 71 1 (2001) 101-109
23. Kang H.A., and Hershey J.W. Effect of initiation factor eIF-5A depletion on protein synthesis and proliferation of Saccharomyces cerevisiae. J. Biol. Chem. 269 6 (1994) 3934-3940
24. Chen Z.P., and Chen K.Y. Marked elevation of hypusine formation activity on eukaryotic initiation factor 5A in v-HA-RAS transformed mouse NIH3T3 cells. Cancer Lett. 115 2 (1997) 235-241
25. Tome M.E., Fiser S.M., Payne C.M., and Gerner E.W. Excess putrescine accumulation inhibits the formation of modified eukaryotic initiation factor 5A (eIF-5A) and induces apoptosis. Biochem. J. 328 Pt 3 (1997) 847-854
26. Clement P.M., Henderson C.A., Jenkins Z.A., Smit-McBride Z., Wolff E.C., Hershey J.W., et al. Identification and characterization of eukaryotic initiation factor 5A-2. Eur. J. Biochem. 270 21 (2003) 4254-4263
27. Ramaswamy S., Ross K.N., Lander E.S., and Golub T.R. A molecular signature of metastasis in primary solid tumors. Nat. Genet. 33 1 (2003) 49-54
28. Stark G.R., Debatisse M., Giulotto E., and Wahl G.M. Recent progress in understanding mechanisms of mammalian DNA amplification. Cell 57 6 (1989) 901-908
29. Clement P.M., Johansson H.E., Wolff E.C., and Park M.H. Differential expression of eIF5A-1 and eIF5A-2 in human cancer cells. FEBS J. 273 6 (2006) 1102-1114